Tandem Capital Management Corp ADV Sells 91 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Tandem Capital Management Corp ADV reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,604 shares of the healthcare conglomerate’s stock after selling 91 shares during the quarter. Tandem Capital Management Corp ADV’s holdings in UnitedHealth Group were worth $1,371,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Bray Capital Advisors raised its holdings in UnitedHealth Group by 0.5% during the third quarter. Bray Capital Advisors now owns 9,616 shares of the healthcare conglomerate’s stock worth $4,848,000 after buying an additional 50 shares during the last quarter. 1900 Wealth Management LLC bought a new position in shares of UnitedHealth Group during the third quarter valued at about $359,000. DAVENPORT & Co LLC grew its position in UnitedHealth Group by 28.8% in the 3rd quarter. DAVENPORT & Co LLC now owns 244,089 shares of the healthcare conglomerate’s stock worth $123,220,000 after purchasing an additional 54,521 shares in the last quarter. BTC Capital Management Inc. boosted its stake in shares of UnitedHealth Group by 2.6% in the 3rd quarter. BTC Capital Management Inc. now owns 14,925 shares of the healthcare conglomerate’s stock worth $7,525,000 after buying an additional 375 shares during the last quarter. Finally, Bellecapital International Ltd. lifted its holdings in UnitedHealth Group by 2.0% during the third quarter. Bellecapital International Ltd. now owns 13,630 shares of the healthcare conglomerate’s stock worth $6,872,000 after acquiring an additional 273 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of research analyst reports. Barclays boosted their target price on shares of UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Truist Financial reissued a “buy” rating and set a $600.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 17th. Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 10th. Finally, TD Cowen dropped their price target on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research note on Wednesday, April 10th. Four investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $570.05.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock traded up $6.58 on Thursday, hitting $493.88. 4,329,383 shares of the company traded hands, compared to its average volume of 4,530,458. The company has a market cap of $454.41 billion, a P/E ratio of 30.19, a P/E/G ratio of 1.41 and a beta of 0.54. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The firm’s 50-day simple moving average is $486.36 and its 200 day simple moving average is $514.42.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company’s revenue was up 8.6% on a year-over-year basis. During the same period in the prior year, the company earned $6.26 EPS. Analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a $1.88 dividend. This represents a $7.52 annualized dividend and a yield of 1.52%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is presently 45.97%.

Insider Activity

In related news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.